Design and Evaluation of a Novel Matrix Type Multiple Units as Biphasic Gastroretentive Drug Delivery Systems

被引:0
作者
Meka Lingam
Thadisetty Ashok
Vobalaboina Venkateswarlu
Yamsani Madhusudan Rao
机构
[1] University College of Pharmaceutical Sciences,Centre for Biopharmaceutics and Pharmacokinetics
[2] Kakatiya University,undefined
来源
AAPS PharmSciTech | / 9卷
关键词
biphasic release; controlled release; dissolution; polymeric coating;
D O I
暂无
中图分类号
学科分类号
摘要
A biphasic gastroretentive floating drug delivery system with multiple-unit mini-tablets based on gas formation technique was developed to maintain constant plasma level of a drug concentration within the therapeutic window. The system consists of loading dose as uncoated core units, and prolonged-release core units are prepared by direct compression process; the latter were coated with three successive layers, one of which is seal coat, an effervescent (sodium bicarbonate) layer, and an outer polymeric layer of polymethacrylates. The formulations were evaluated for quality control tests, and all the parameters evaluated were within the acceptable limits. The system using Eudragit RL30D and combination of them as polymeric layer could float within acceptable time. The drug release was linear with the square root of time. The rapid floating and the controlled release properties were achieved in this present study. When compared with the theoretical release profile, the similarity factor of formulation with coating of RS:RL (1:3)–7.5%, was observed to be 74, which is well fitted into zero-order kinetics confirming that the release from formulation is close to desired release profile. The stability samples showed no significant change in dissolution profiles (p > 0.05). In vivo gastric residence time was examined by radiograms, and it was observed that the units remained in the stomach for about 5 h.
引用
收藏
相关论文
共 37 条
  • [1] Rouge N.(1997)Screening of potentially floating excipients for Minitablets S.T.P. Pharm. Sci. 7 386-392
  • [2] Cole E. T.(1999)Formulation of biphasic release tablets containing slightly soluble drugs Eur. J. Pharm. Biopharm. 48 37-42
  • [3] Doelker E.(2002)Comparative evaluation of wet granulation and direct compression methods for preparation of controlled release ranitidine HCL tablets Indian J. Pharm. Sci. 64 285-125
  • [4] Buri P.(1990)Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases Clin. Pharmacokinet. 19 94-870
  • [5] Maggi L.(1989)Ranitidine: an updated review of its pharmacodynamics and pharmacokinetic properties and therapeutic use in peptic ulcer and other allied diseases Drugs. 37 801-165
  • [6] Machiste E. O.(2001)Colonic metabolism of ranitidine: implications for its delivery and absorption Int. J. Pharm. 227 157-133
  • [7] Torre M. L.(2006)Once-daily tablet formulation and in vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: a technical note AAPS PharmSciTech. 7 78-74
  • [8] Conte U.(2001)Modeling and comparison dissolution profiles Int. J. Pharm. 13 123-204
  • [9] Somade S.(1996)Mathematical comparison of curves with an emphasis on Pharm. Tech. 20 64-21
  • [10] Singh K.(2000) dissolution profiles PSTT 3 198-184